메뉴 건너뛰기
Journal of Virology
Volumn 89, Issue 14, 2015, Pages 7262-7276
Rift Valley fever virus MP-12 vaccine is fully attenuated by a combination of partial attenuations in the S, M, and L segments
Author keywords

[No Author keywords available]
Indexed keywords

GENOMIC RNA; LIVE VACCINE; RIFT VALLEY FEVER VIRUS MP 12 VACCINE; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN GC; VIRUS ENVELOPE PROTEIN GN; VIRUS ENVELOPE PROTEIN M; VIRUS ENVELOPE PROTEIN NSM; VIRUS NUCLEOPROTEIN; VIRUS NUCLEOPROTEIN S; VIRUS VACCINE;
EID: 84931034621     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00135-15     Document Type: Article
Times cited : (62)
References (78)
  • 2
    • 77957852165 scopus 로고    scopus 로고
    • Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention
    • Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. 2010. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41:61. http://dx.doi.org/10.1051/vetres/2010033.
    • (2010) Vet Res , vol.41 , pp. 61
    • Pepin, M.1    Bouloy, M.2    Bird, B.H.3    Kemp, A.4    Paweska, J.5
  • 3
    • 34948862521 scopus 로고    scopus 로고
    • Bunyaviridae
    • 5th ed. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Lippincott Williams & Wilkins, Philadelphia, PA
    • Schmaljohn C, Nichol ST. 2007. Bunyaviridae, p 1741-1789. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
    • (2007) Fields virology , pp. 1741-1789
    • Schmaljohn, C.1    Nichol, S.T.2
  • 4
    • 0022261874 scopus 로고
    • Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya
    • Linthicum KJ, Davies FG, Kairo A, Bailey CL. 1985. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg (Lond) 95:197-209.
    • (1985) J Hyg (Lond) , vol.95 , pp. 197-209
    • Linthicum, K.J.1    Davies, F.G.2    Kairo, A.3    Bailey, C.L.4
  • 7
    • 0024510591 scopus 로고
    • General aspects of the 1987 Rift Valley fever epidemic in Mauritania
    • Digoutte JP, Peters CJ. 1989. General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol 140:27-30. http://dx.doi.org/10.1016/S0923-2516(89)80081-0.
    • (1989) Res Virol , vol.140 , pp. 27-30
    • Digoutte, J.P.1    Peters, C.J.2
  • 8
    • 77956262894 scopus 로고    scopus 로고
    • Advances in Rift Valley fever research: insights for disease prevention
    • LaBeaud AD, Kazura JW, King CH. 2010. Advances in Rift Valley fever research: insights for disease prevention. Curr Opin Infect Dis 23:403-408. http://dx.doi.org/10.1097/QCO.0b013e32833c3da6.
    • (2010) Curr Opin Infect Dis , vol.23 , pp. 403-408
    • LaBeaud, A.D.1    Kazura, J.W.2    King, C.H.3
  • 9
    • 79957850163 scopus 로고    scopus 로고
    • The pathogenesis of Rift Valley fever
    • Ikegami T, Makino S. 2011. The pathogenesis of Rift Valley fever. Viruses 3:493-519. http://dx.doi.org/10.3390/v3050493.
    • (2011) Viruses , vol.3 , pp. 493-519
    • Ikegami, T.1    Makino, S.2
  • 10
    • 0000142542 scopus 로고
    • Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from east Africa
    • Daubney R, Hudson JR. 1931. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from east Africa. J Pathol Bacteriol 34:545-579. http://dx.doi.org/10.1002/path.1700340418.
    • (1931) J Pathol Bacteriol , vol.34 , pp. 545-579
    • Daubney, R.1    Hudson, J.R.2
  • 11
    • 33947362031 scopus 로고    scopus 로고
    • Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry
    • Bird BH, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. 2007. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J Virol 81:2805-2816. http://dx.doi.org/10.1128/JVI.02095-06.
    • (2007) J Virol , vol.81 , pp. 2805-2816
    • Bird, B.H.1    Khristova, M.L.2    Rollin, P.E.3    Ksiazek, T.G.4    Nichol, S.T.5
  • 13
    • 80052059049 scopus 로고    scopus 로고
    • Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance
    • Carroll SA, Reynes JM, Khristova ML, Andriamandimby SF, Rollin PE, Nichol ST. 2011. Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting from virus introductions from the East African mainland rather than enzootic maintenance. J Virol 85:6162-6167. http://dx.doi.org/10.1128/JVI.00335-11.
    • (2011) J Virol , vol.85 , pp. 6162-6167
    • Carroll, S.A.1    Reynes, J.M.2    Khristova, M.L.3    Andriamandimby, S.F.4    Rollin, P.E.5    Nichol, S.T.6
  • 14
    • 79960881605 scopus 로고    scopus 로고
    • Potential effects of Rift Valley fever in the United States
    • Hartley DM, Rinderknecht JL, Nipp TL, Clarke NP, Snowder GD, National Center for Foreign Animal and Zoonotic Disease Defense Advisory Group on Rift Valley Fever. 2011. Potential effects of Rift Valley fever in the United States. Emerg Infect Dis 17:e1. http://dx.doi.org/10.3201/eid1708.101088.
    • (2011) Emerg Infect Dis , vol.17
    • Hartley, D.M.1    Rinderknecht, J.L.2    Nipp, T.L.3    Clarke, N.P.4    Snowder, G.D.5
  • 15
    • 84880254667 scopus 로고    scopus 로고
    • Tempering the risk: Rift Valley fever and bioterrorism
    • Dar O, Hogarth S, McIntyre S. 2013. Tempering the risk: Rift Valley fever and bioterrorism. Trop Med Int Health 18:1036-1041. http://dx.doi.org/10.1111/tmi.12108.
    • (2013) Trop Med Int Health , vol.18 , pp. 1036-1041
    • Dar, O.1    Hogarth, S.2    McIntyre, S.3
  • 16
    • 84931051765 scopus 로고    scopus 로고
    • Challenges and practices in building and implementing biosafety and biosecurity programs to enable basic and translational research with select agents
    • Jonsson CB, Cole KS, Roy CJ, Perlin DS, Byrne G. 2013. Challenges and practices in building and implementing biosafety and biosecurity programs to enable basic and translational research with select agents. J Bioterror Biodef Suppl 3:12634. http://dx.doi.org/10.4172/2157-2526.S3-015.
    • (2013) J Bioterror Biodef Suppl , vol.3 , pp. 12634
    • Jonsson, C.B.1    Cole, K.S.2    Roy, C.J.3    Perlin, D.S.4    Byrne, G.5
  • 17
    • 84871876858 scopus 로고    scopus 로고
    • The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment
    • Shurtleff AC, Garza N, Lackemeyer M, Carrion R, Jr, Griffiths A, Patterson J, Edwin SS, Bavari S. 2012. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses 4:3932-3951. http://dx.doi.org/10.3390/v4123932.
    • (2012) Viruses , vol.4 , pp. 3932-3951
    • Shurtleff, A.C.1    Garza, N.2    Lackemeyer, M.3    Carrion, R.4    Griffiths, A.5    Patterson, J.6    Edwin, S.S.7    Bavari, S.8
  • 18
    • 0039566586 scopus 로고
    • Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine
    • Smithburn KC. 1949. Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Br J Exp Pathol 30:1-16.
    • (1949) Br J Exp Pathol , vol.30 , pp. 1-16
    • Smithburn, K.C.1
  • 19
    • 77955982783 scopus 로고    scopus 로고
    • Rift valley fever vaccines
    • Ikegami T, Makino S. 2009. Rift valley fever vaccines. Vaccine 27(Suppl 4):D69-D72. http://dx.doi.org/10.1016/j.vaccine.2009.07.046.
    • (2009) Vaccine , vol.27 , pp. D69-D72
    • Ikegami, T.1    Makino, S.2
  • 20
    • 0344513779 scopus 로고
    • The development of a formalin-killed Rift Valley fever virus vaccine for use in man
    • Randall R, Gibbs CJ, Jr, Aulisio CG, Binn LN, Harrison VR. 1962. The development of a formalin-killed Rift Valley fever virus vaccine for use in man. J Immunol 89:660-671.
    • (1962) J Immunol , vol.89 , pp. 660-671
    • Randall, R.1    Gibbs, C.J.2    Aulisio, C.G.3    Binn, L.N.4    Harrison, V.R.5
  • 22
    • 0033588528 scopus 로고    scopus 로고
    • Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience
    • Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ. 1999. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 18:181-189. http://dx.doi.org/10.1016/S0264-410X(99)00218-2.
    • (1999) Vaccine , vol.18 , pp. 181-189
    • Pittman, P.R.1    Liu, C.T.2    Cannon, T.L.3    Makuch, R.S.4    Mangiafico, J.A.5    Gibbs, P.H.6    Peters, C.J.7
  • 23
    • 0018642694 scopus 로고
    • The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies
    • Meegan JM. 1979. The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies. TransRSoc TropMed Hyg 73:618-623. http://dx.doi.org/10.1016/0035-9203(79)90004-X.
    • (1979) TransRSoc TropMed Hyg , vol.73 , pp. 618-623
    • Meegan, J.M.1
  • 24
    • 0022258169 scopus 로고
    • Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development
    • Caplen H, Peters CJ, Bishop DH. 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66:2271-2277. http://dx.doi.org/10.1099/0022-1317-66-10-2271.
    • (1985) J Gen Virol , vol.66 , pp. 2271-2277
    • Caplen, H.1    Peters, C.J.2    Bishop, D.H.3
  • 25
    • 84870660408 scopus 로고    scopus 로고
    • Genetic subpopulations of Rift Valley fever ZH548, MP-12 and recombinant MP-12 strains
    • Lokugamage N, Freiberg AN, Morrill JC, Ikegami T. 2012. Genetic subpopulations of Rift Valley fever ZH548, MP-12 and recombinant MP-12 strains. J Virol 86:13566-13575. http://dx.doi.org/10.1128/JVI.02081-12.
    • (2012) J Virol , vol.86 , pp. 13566-13575
    • Lokugamage, N.1    Freiberg, A.N.2    Morrill, J.C.3    Ikegami, T.4
  • 26
    • 0026062243 scopus 로고
    • Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep
    • Morrill JC, Carpenter L, Taylor D, Ramsburg HH, Quance J, Peters CJ. 1991. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 9:35-41. http://dx.doi.org/10.1016/0264-410X(91)90314-V.
    • (1991) Vaccine , vol.9 , pp. 35-41
    • Morrill, J.C.1    Carpenter, L.2    Taylor, D.3    Ramsburg, H.H.4    Quance, J.5    Peters, C.J.6
  • 27
    • 0030874806 scopus 로고    scopus 로고
    • Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids
    • Morrill JC, Mebus CA, Peters CJ. 1997. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 58:1110-1114.
    • (1997) Am J Vet Res , vol.58 , pp. 1110-1114
    • Morrill, J.C.1    Mebus, C.A.2    Peters, C.J.3
  • 28
    • 0030874805 scopus 로고    scopus 로고
    • Safety and efficacy of a mutagenattenuated Rift Valley fever virus vaccine in cattle
    • Morrill JC, Mebus CA, Peters CJ. 1997. Safety and efficacy of a mutagenattenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 58:1104-1109.
    • (1997) Am J Vet Res , vol.58 , pp. 1104-1109
    • Morrill, J.C.1    Mebus, C.A.2    Peters, C.J.3
  • 29
    • 0023368922 scopus 로고
    • Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes
    • Morrill JC, Jennings GB, Caplen H, Turell MJ, Johnson AJ, Peters CJ. 1987. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 48:1042-1047.
    • (1987) Am J Vet Res , vol.48 , pp. 1042-1047
    • Morrill, J.C.1    Jennings, G.B.2    Caplen, H.3    Turell, M.J.4    Johnson, A.J.5    Peters, C.J.6
  • 30
    • 0038512604 scopus 로고    scopus 로고
    • Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys
    • Morrill JC, Peters CJ. 2003. Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 21:2994-3002. http://dx.doi.org/10.1016/S0264-410X(03)00131-2.
    • (2003) Vaccine , vol.21 , pp. 2994-3002
    • Morrill, J.C.1    Peters, C.J.2
  • 31
    • 79960850278 scopus 로고    scopus 로고
    • Mucosal immunization of rhesus macaques with Rift Valley fever MP-12 vaccine
    • Morrill JC, Peters CJ. 2011. Mucosal immunization of rhesus macaques with Rift Valley fever MP-12 vaccine. J Infect Dis 204:617-625. http://dx.doi.org/10.1093/infdis/jir354.
    • (2011) J Infect Dis , vol.204 , pp. 617-625
    • Morrill, J.C.1    Peters, C.J.2
  • 32
    • 79958710636 scopus 로고    scopus 로고
    • Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus
    • Morrill JC, Peters CJ. 2011. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus. J Infect Dis 204:229-236. http://dx.doi.org/10.1093/infdis/jir249.
    • (2011) J Infect Dis , vol.204 , pp. 229-236
    • Morrill, J.C.1    Peters, C.J.2
  • 33
    • 70349459608 scopus 로고    scopus 로고
    • Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines
    • Bouloy M, Flick R. 2009. Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res 84:101-118. http://dx.doi.org/10.1016/j.antiviral.2009.08.002.
    • (2009) Antiviral Res , vol.84 , pp. 101-118
    • Bouloy, M.1    Flick, R.2
  • 34
    • 0036519948 scopus 로고    scopus 로고
    • Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep
    • Hunter P, Erasmus BJ, Vorster JH. 2002. Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep. Onderstepoort J Vet Res 69:95-98.
    • (2002) Onderstepoort J Vet Res , vol.69 , pp. 95-98
    • Hunter, P.1    Erasmus, B.J.2    Vorster, J.H.3
  • 36
    • 78149353044 scopus 로고    scopus 로고
    • Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription
    • Reguera J, Weber F, Cusack S. 2010. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog 6:e1001101. http://dx.doi.org/10.1371/journal.ppat.1001101.
    • (2010) PLoS Pathog , vol.6
    • Reguera, J.1    Weber, F.2    Cusack, S.3
  • 37
    • 0029073155 scopus 로고
    • The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules
    • Lopez N, Muller R, Prehaud C, Bouloy M. 1995. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J Virol 69:3972-3979.
    • (1995) J Virol , vol.69 , pp. 3972-3979
    • Lopez, N.1    Muller, R.2    Prehaud, C.3    Bouloy, M.4
  • 38
    • 17444414223 scopus 로고    scopus 로고
    • Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system
    • Ikegami T, Peters CJ, Makino S. 2005. Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J Virol 79:5606-5615. http://dx.doi.org/10.1128/JVI.79.9.5606-5615.2005.
    • (2005) J Virol , vol.79 , pp. 5606-5615
    • Ikegami, T.1    Peters, C.J.2    Makino, S.3
  • 39
    • 55249110450 scopus 로고    scopus 로고
    • Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography
    • Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ. 2008. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol 82:10341-10348. http://dx.doi.org/10.1128/JVI.01191-08.
    • (2008) J Virol , vol.82 , pp. 10341-10348
    • Freiberg, A.N.1    Sherman, M.B.2    Morais, M.C.3    Holbrook, M.R.4    Watowich, S.J.5
  • 40
    • 64049094507 scopus 로고    scopus 로고
    • Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers
    • Huiskonen JT, Overby AK, Weber F, Grunewald K. 2009. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J Virol 83:3762-3769. http://dx.doi.org/10.1128/JVI.02483-08.
    • (2009) J Virol , vol.83 , pp. 3762-3769
    • Huiskonen, J.T.1    Overby, A.K.2    Weber, F.3    Grunewald, K.4
  • 41
    • 63549107008 scopus 로고    scopus 로고
    • Singleparticle cryo-electron microscopy of Rift Valley fever virus
    • Sherman MB, Freiberg AN, Holbrook MR, Watowich SJ. 2009. Singleparticle cryo-electron microscopy of Rift Valley fever virus. Virology 387: 11-15. http://dx.doi.org/10.1016/j.virol.2009.02.038.
    • (2009) Virology , vol.387 , pp. 11-15
    • Sherman, M.B.1    Freiberg, A.N.2    Holbrook, M.R.3    Watowich, S.J.4
  • 42
    • 0036889157 scopus 로고    scopus 로고
    • Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein
    • Gerrard SR, Nichol ST. 2002. Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J Virol 76:12200-12210. http://dx.doi.org/10.1128/JVI.76.23.12200-12210.2002.
    • (2002) J Virol , vol.76 , pp. 12200-12210
    • Gerrard, S.R.1    Nichol, S.T.2
  • 43
    • 33751440340 scopus 로고    scopus 로고
    • Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins
    • Gerrard SR, Nichol ST. 2007. Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology 357:124-133. http://dx.doi.org/10.1016/j.virol.2006.08.002.
    • (2007) Virology , vol.357 , pp. 124-133
    • Gerrard, S.R.1    Nichol, S.T.2
  • 45
    • 84869238905 scopus 로고    scopus 로고
    • Rift Valley fever virus strain MP-12 enters mammalian host cells via caveolae-mediated endocytosis
    • Harmon B, Schudel BR, Maar D, Kozina C, Ikegami T, Tseng CT, Negrete OA. 2012. Rift Valley fever virus strain MP-12 enters mammalian host cells via caveolae-mediated endocytosis. J Virol 86:12954-12970. http://dx.doi.org/10.1128/JVI.02242-12.
    • (2012) J Virol , vol.86 , pp. 12954-12970
    • Harmon, B.1    Schudel, B.R.2    Maar, D.3    Kozina, C.4    Ikegami, T.5    Tseng, C.T.6    Negrete, O.A.7
  • 46
    • 0035152344 scopus 로고    scopus 로고
    • Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs
    • Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O. 2001. Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J Virol 75:1371-1377. http://dx.doi.org/10.1128/JVI.75.3.1371-1377.2001.
    • (2001) J Virol , vol.75 , pp. 1371-1377
    • Bouloy, M.1    Janzen, C.2    Vialat, P.3    Khun, H.4    Pavlovic, J.5    Huerre, M.6    Haller, O.7
  • 47
    • 0033982965 scopus 로고    scopus 로고
    • The S segment of Rift Valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice
    • Vialat P, Billecocq A, Kohl A, Bouloy M. 2000. The S segment of Rift Valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J Virol 74:1538-1543. http://dx.doi.org/10.1128/JVI.74.3.1538-1543.2000.
    • (2000) J Virol , vol.74 , pp. 1538-1543
    • Vialat, P.1    Billecocq, A.2    Kohl, A.3    Bouloy, M.4
  • 48
    • 1342264311 scopus 로고    scopus 로고
    • TFIIH transcription factor, a target for the Rift Valley hemor-rhagicfevervirus
    • Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. 2004. TFIIH transcription factor, a target for the Rift Valley hemor-rhagicfevervirus. Cell 116:541-550.http://dx.doi.org/10.1016/S0092-8674(04)00132-1.
    • (2004) Cell , vol.116 , pp. 541-550
    • Le May, N.1    Dubaele, S.2    Proietti De Santis, L.3    Billecocq, A.4    Bouloy, M.5    Egly, J.M.6
  • 49
    • 80052073169 scopus 로고    scopus 로고
    • NSs protein of Rift Valley fever virus promotes post-translational downregulation of the TFIIH subunit p62
    • Kalveram B, Lihoradova O, Ikegami T. 2011. NSs protein of Rift Valley fever virus promotes post-translational downregulation of the TFIIH subunit p62. J Virol 85:6234-6243. http://dx.doi.org/10.1128/JVI.02255-10.
    • (2011) J Virol , vol.85 , pp. 6234-6243
    • Kalveram, B.1    Lihoradova, O.2    Ikegami, T.3
  • 50
    • 84894536027 scopus 로고    scopus 로고
    • Virulence factor NSs of Rift Valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH
    • Kainulainen M, Habjan M, Hubel P, Busch L, Lau S, Colinge J, Superti-Furga G, Pichlmair A, Weber F. 2014. Virulence factor NSs of Rift Valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH. J Virol 88:3464-3473. http://dx.doi.org/10.1128/JVI.02914-13.
    • (2014) J Virol , vol.88 , pp. 3464-3473
    • Kainulainen, M.1    Habjan, M.2    Hubel, P.3    Busch, L.4    Lau, S.5    Colinge, J.6    Superti-Furga, G.7    Pichlmair, A.8    Weber, F.9
  • 51
    • 4444374579 scopus 로고    scopus 로고
    • NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription
    • Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78:9798-9806. http://dx.doi.org/10.1128/JVI.78.18.9798-9806.2004.
    • (2004) J Virol , vol.78 , pp. 9798-9806
    • Billecocq, A.1    Spiegel, M.2    Vialat, P.3    Kohl, A.4    Weber, F.5    Bouloy, M.6    Haller, O.7
  • 53
    • 61449213995 scopus 로고    scopus 로고
    • Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation
    • Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. 2009. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5:e1000287. http://dx.doi.org/10.1371/journal.ppat.1000287.
    • (2009) PLoS Pathog , vol.5
    • Ikegami, T.1    Narayanan, K.2    Won, S.3    Kamitani, W.4    Peters, C.J.5    Makino, S.6
  • 54
    • 66149086445 scopus 로고    scopus 로고
    • NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNAdependent protein kinase
    • Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F. 2009. NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNAdependent protein kinase. J Virol 83:4365-4375. http://dx.doi.org/10.1128/JVI.02148-08.
    • (2009) J Virol , vol.83 , pp. 4365-4375
    • Habjan, M.1    Pichlmair, A.2    Elliott, R.M.3    Overby, A.K.4    Glatter, T.5    Gstaiger, M.6    Superti-Furga, G.7    Unger, H.8    Weber, F.9
  • 55
    • 37049008494 scopus 로고    scopus 로고
    • NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis
    • Won S, Ikegami T, Peters CJ, Makino S. 2007. NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol 81:13335-13345. http://dx.doi.org/10.1128/JVI.01238-07.
    • (2007) J Virol , vol.81 , pp. 13335-13345
    • Won, S.1    Ikegami, T.2    Peters, C.J.3    Makino, S.4
  • 56
    • 84871988406 scopus 로고    scopus 로고
    • The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts anti-apoptotic function
    • Terasaki K, Won S, Makino S. 2013. The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts anti-apoptotic function. J Virol 87:676-682. http://dx.doi.org/10.1128/JVI.02192-12.
    • (2013) J Virol , vol.87 , pp. 676-682
    • Terasaki, K.1    Won, S.2    Makino, S.3
  • 57
    • 84895753857 scopus 로고    scopus 로고
    • Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes
    • Kading RC, Crabtree MB, Bird BH, Nichol ST, Erickson BR, Horiuchi K, Biggerstaff BJ, Miller BR. 2014. Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes. PLoS Negl Trop Dis 8:e2670. http://dx.doi.org/10.1371/journal.pntd.0002670.
    • (2014) PLoS Negl Trop Dis , vol.8
    • Kading, R.C.1    Crabtree, M.B.2    Bird, B.H.3    Nichol, S.T.4    Erickson, B.R.5    Horiuchi, K.6    Biggerstaff, B.J.7    Miller, B.R.8
  • 58
    • 84863641669 scopus 로고    scopus 로고
    • Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection
    • Crabtree MB, Kent Crockett RJ, Bird BH, Nichol ST, Erickson BR, Biggerstaff BJ, Horiuchi K, Miller BR. 2012. Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis 6:e1639. http://dx.doi.org/10.1371/journal.pntd.0001639.
    • (2012) PLoS Negl Trop Dis , vol.6
    • Crabtree, M.B.1    Kent Crockett, R.J.2    Bird, B.H.3    Nichol, S.T.4    Erickson, B.R.5    Biggerstaff, B.J.6    Horiuchi, K.7    Miller, B.R.8
  • 59
    • 84897546161 scopus 로고    scopus 로고
    • Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells
    • Weingartl HM, Zhang S, Marszal P, McGreevy A, Burton L, Wilson WC. 2014. Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS One 9:e87385. http://dx.doi.org/10.1371/journal.pone.0087385.
    • (2014) PLoS One , vol.9
    • Weingartl, H.M.1    Zhang, S.2    Marszal, P.3    McGreevy, A.4    Burton, L.5    Wilson, W.C.6
  • 60
    • 0025073601 scopus 로고
    • Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine
    • Saluzzo JF, Smith JF. 1990. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8:369-375. http://dx.doi.org/10.1016/0264-410X(90)90096-5.
    • (1990) Vaccine , vol.8 , pp. 369-375
    • Saluzzo, J.F.1    Smith, J.F.2
  • 61
    • 49049097662 scopus 로고    scopus 로고
    • RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses
    • Billecocq A, Gauliard N, Le May N, Elliott RM, Flick R, Bouloy M. 2008. RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378: 377-384. http://dx.doi.org/10.1016/j.virol.2008.05.033.
    • (2008) Virology , vol.378 , pp. 377-384
    • Billecocq, A.1    Gauliard, N.2    Le May, N.3    Elliott, R.M.4    Flick, R.5    Bouloy, M.6
  • 62
    • 0041977209 scopus 로고    scopus 로고
    • Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system
    • Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N. 2003. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 47:613-617. http://dx.doi.org/10.1111/j.1348-0421.2003.tb03424.x.
    • (2003) Microbiol Immunol , vol.47 , pp. 613-617
    • Ito, N.1    Takayama-Ito, M.2    Yamada, K.3    Hosokawa, J.4    Sugiyama, M.5    Minamoto, N.6
  • 63
    • 77956317429 scopus 로고    scopus 로고
    • Rapid accumulation of virulent Rift Valley fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the mRNA
    • Morrill JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, Terasaki K, Zamoto-Niikura A, Peters CJ, Makino S. 2010. Rapid accumulation of virulent Rift Valley fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the mRNA. PLoS One 5:e9986. http://dx.doi.org/10.1371/journal.pone.0009986.
    • (2010) PLoS One , vol.5
    • Morrill, J.C.1    Ikegami, T.2    Yoshikawa-Iwata, N.3    Lokugamage, N.4    Won, S.5    Terasaki, K.6    Zamoto-Niikura, A.7    Peters, C.J.8    Makino, S.9
  • 64
    • 83455195409 scopus 로고    scopus 로고
    • Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy
    • Kalveram B, Lihoradova O, Indran SV, Ikegami T. 2011. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J Vis Exp 2011:e3400. http://dx.doi.org/10.3791/3400.
    • (2011) J Vis Exp , vol.2011
    • Kalveram, B.1    Lihoradova, O.2    Indran, S.V.3    Ikegami, T.4
  • 65
    • 33644777662 scopus 로고    scopus 로고
    • Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene
    • Ikegami T, Won S, Peters CJ, Makino S. 2006. Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80:2933-2940. http://dx.doi.org/10.1128/JVI.80.6.2933-2940.2006.
    • (2006) J Virol , vol.80 , pp. 2933-2940
    • Ikegami, T.1    Won, S.2    Peters, C.J.3    Makino, S.4
  • 66
    • 33746784160 scopus 로고    scopus 로고
    • NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture
    • Won S, Ikegami T, Peters CJ, Makino S. 2006. NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol 80:8274-8278. http://dx.doi.org/10.1128/JVI.00476-06.
    • (2006) J Virol , vol.80 , pp. 8274-8278
    • Won, S.1    Ikegami, T.2    Peters, C.J.3    Makino, S.4
  • 69
    • 0024202981 scopus 로고
    • Genetic variation among geographic isolates of Rift Valley fever virus
    • Battles JK, Dalrymple JM. 1988. Genetic variation among geographic isolates of Rift Valley fever virus. Am J Trop Med Hyg 39:617-631.
    • (1988) Am J Trop Med Hyg , vol.39 , pp. 617-631
    • Battles, J.K.1    Dalrymple, J.M.2
  • 71
    • 77953178088 scopus 로고    scopus 로고
    • Clinical chemistry of the laboratory mouse
    • 2nd ed. Fox JG, Barthold SW, Davisson MT, Newcomer EC, Quimby FW, Smith AL (ed), Normative biology, husbandry, and models. Academic Press, Burlington, MA
    • Quimby FW, Luong RH. 2007. Clinical chemistry of the laboratory mouse, p 171-216. In Fox JG, Barthold SW, Davisson MT, Newcomer EC, Quimby FW, Smith AL (ed), The mouse in biomedical research, 2nd ed, vol III. Normative biology, husbandry, and models. Academic Press, Burlington, MA.
    • (2007) The mouse in biomedical research , vol.3 , pp. 171-216
    • Quimby, F.W.1    Luong, R.H.2
  • 73
    • 84865282834 scopus 로고    scopus 로고
    • Molecular biology and genetic diversity of Rift Valley fever virus
    • Ikegami T. 2012. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res 95:293-310. http://dx.doi.org/10.1016/j.antiviral.2012.06.001.
    • (2012) Antiviral Res , vol.95 , pp. 293-310
    • Ikegami, T.1
  • 74
    • 84857874316 scopus 로고    scopus 로고
    • Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse
    • Gray KK, Worthy MN, Juelich TL, Agar SL, Poussard A, Ragland D, Freiberg AN, Holbrook MR. 2012. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis 6:e1529. http://dx.doi.org/10.1371/journal.pntd.0001529.
    • (2012) PLoS Negl Trop Dis , vol.6
    • Gray, K.K.1    Worthy, M.N.2    Juelich, T.L.3    Agar, S.L.4    Poussard, A.5    Ragland, D.6    Freiberg, A.N.7    Holbrook, M.R.8
  • 75
    • 84875550079 scopus 로고    scopus 로고
    • Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase
    • Kalveram B, Ikegami T. 2013. Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase. J Virol 87: 3710-3718. http://dx.doi.org/10.1128/JVI.02506-12.
    • (2013) J Virol , vol.87 , pp. 3710-3718
    • Kalveram, B.1    Ikegami, T.2
  • 77
    • 84885184339 scopus 로고    scopus 로고
    • Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves
    • Morrill JC, Laughlin RC, Lokugamage N, Wu J, Pugh R, Kanani P, Adams LG, Makino S, Peters CJ. 2013. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine 31:4988-4994. http://dx.doi.org/10.1016/j.vaccine.2013.08.003.
    • (2013) Vaccine , vol.31 , pp. 4988-4994
    • Morrill, J.C.1    Laughlin, R.C.2    Lokugamage, N.3    Wu, J.4    Pugh, R.5    Kanani, P.6    Adams, L.G.7    Makino, S.8    Peters, C.J.9
  • 78
    • 84893839975 scopus 로고    scopus 로고
    • Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor
    • Lihoradova O, Ikegami T. 2014. Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor. Future Virol 9:27-39. http://dx.doi.org/10.2217/fvl.13.117.
    • (2014) Future Virol , vol.9 , pp. 27-39
    • Lihoradova, O.1    Ikegami, T.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.